Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MTARC2 pseudogene 1 (MTARC2P1) is a processed pseudogene related to the functional mitochondrial amidoxime reducing component 2 gene (MTARC2). Pseudogenes are typically genomic DNA sequences similar to known genes but are non-functional due to mutations or truncations, and they do not encode active proteins. Thus, MTARC2P1 does not act as a receptor, enzyme, transporter, or other protein target and is not involved in disease mechanisms or drug interactions. MTARC2P1 is registered in gene databases as a pseudogene; it does not encode a protein and has no described biological function or disease relevance. The functional MTARC2 gene codes for an enzyme involved in N-hydroxylated substrate reduction, but MTARC2P1 is not a functional gene product and should not be considered as a drug target, biomarker, or safety concern. It should not be listed as a therapeutic target for drug development. No molecular function, disease associations, or known drug interactions. Entry is likely incorrect as a target request in drug discovery and translational research contexts. If structured information is needed for a target, refer to MTARC2 (mitochondrial amidoxime reducing component 2), not MTARC2P1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MTARC2 pseudogene 1 (MTARC2P1).